KALA BIO
KALA
36 hedge funds and large institutions have $33.7M invested in KALA BIO in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 10 closing their positions.
1.67% less ownership
Funds ownership: 38.91% → 37.23% (-1.7%)
8% less funds holding
Funds holding: 39 → 36 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
43% less capital inflows, than outflows
Capital inflows: $2.12M | Capital outflows: $3.7M
54% less call options, than puts
Call options by funds: $79K | Put options by funds: $172K
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$708K |
| 2 |
Graypoint LLC
Albany,
New York
|
+$550K |
| 3 |
Bridgeway Capital Management
Houston,
Texas
|
+$157K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$157K |
| 5 |
Jane Street
New York
|
+$157K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$776K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$550K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$472K |
| 4 |
Vahanian & Associates Financial Planning
Saratoga Springs,
New York
|
-$472K |
| 5 |
Goldman Sachs
New York
|
-$157K |
KALA Hedge Fund Activity: Q1 2022 in Review
36 of the 6,365 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2022, worth a combined $33.7M — up 9.1% from $30.9M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of KALA and 7 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 3 added.
The largest buyer was Board of Trustees of The Leland Stanford Junior University, opening a new position worth an estimated $708K. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $776K sold.
- 36 institutional investors held KALA BIO (KALA) as of Q1 2022, down from 39 in Q4 2021.
- Funds reported $33.7M of KALA BIO stock for Q1 2022, up 9.1% quarter-over-quarter.
- 7 funds opened new KALA BIO positions in Q1 2022 and 10 closed out, a net change of -3 holders.
- The largest KALA BIO buyer in Q1 2022 was Board of Trustees of The Leland Stanford Junior University, an estimated $708K added.
- The largest KALA BIO seller in Q1 2022 was Pictet Asset Management (Switzerland), an estimated $776K sold.
Based on aggregated 13F filings for Q1 2022.